ArticleWorld journal of clinical oncology2022

Immune checkpoint inhibitors in head and neck squamous cell carcinoma: A systematic review of phase-3 clinical trials.

Jissy Vijo Poulose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.